Virtual-reality based physiotherapy during inpatient treatment with high-dose chemotherapy for acute leucemia or autologous or allogeneic stem cell transplantatio
Not Applicable
- Conditions
- AML, ALL in induction, autologous and allogeneic HSCT
- Registration Number
- DRKS00031095
- Lead Sponsor
- SKH Campus Lübeck Klinik für Hämatologie und Onkologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
• Written informed consent
• Ability to follow instructions in German or English
• Inpatient treatment for one of the following therapies:
• High-dose chemotherapy for acute leukaemia
• Autologous or allogeneic stem cell transplantation
Exclusion Criteria
• Serious cardiac diseases (e.g. heart failure NYHA III, myocardial infarction <3 months)
• Severe infection or sepsis CTCAE v5 > III
• Severe pulmonary global insufficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility, valuation takes place at the end of the study via interviews
- Secondary Outcome Measures
Name Time Method Strength, mobility, cognitive outcome, anxiety, depression, QoL; with evaluation over time of therapy well as at the end of treatment